Key facts, as of
As of October 13, 2026, Universal Health Services (UHS) trades at $178.83, down 8.8% over the past year. Its 52-week range runs from $140.08 to $246.33; the price is 27.4% below that high. It is 27.4% below its all-time high of $246.33, reached in November 2025. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +47.7%, against +312.9% for the S&P 500 (SPY). It sits 0.3% below its 200-day average of $179.34, the usual sign of a long-term downtrend. Its 30-day volatility is 21.9% annualized, which we rate medium risk. It has a trailing P/E of 7.4 and a dividend yield of 0.45%.
Cite: Portfolio Terminal, "Universal Health Services (UHS) stock analysis", 2026-10-13. https://portfolio-terminal.com/analyse/uhs
Where it trades today
trading 36% of the way up its 52-week range
How the price has moved
How far it is from its record
Universal Health Services (UHS) is 27.4% below its all-time high of $246.33, reached in November 2025. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +47.7%, against +312.9% for the S&P 500 (SPY).
What to weigh before acting
What Matters Now
- The read on the stock is often driven by pipeline durability, reimbursement pressure, and whether new launches can offset patent cliffs.
- UHS trades at 7.4x earnings versus 22.0x for the sector, which means the rerating case depends on proving the discount is too harsh.
- UHS carries a beta of 1.03, which means the stock should be judged on how it affects total portfolio swings, not just on standalone upside.
- Relative performance versus UNH, JNJ, PFE matters here because leadership inside healthcare rarely stays static for long.
Portfolio Use Case
- UHS is more useful for investors comparing conviction names inside healthcare than for someone looking for a passive “set and forget” holding.
- The risk profile looks balanced enough for a diversified core-plus portfolio, provided the position size reflects sector concentration.
- The stock becomes more useful when paired with an explicit catalyst watchlist, because sector sentiment can shift quickly around policy, rates, or pipeline news.
What Would Change the View
- The view would need revisiting if peers such as UNH, JNJ, PFE start winning the marginal flow or posting cleaner operating momentum.
Methodology
- Price, market cap, beta, yield, and liquidity fields for UHS come from Yahoo Finance quote and summary data.
- 30-day volatility is calculated from recent daily returns and annualized using a 252-trading-day convention.
- Sector context uses stored benchmark averages for Healthcare so each page compares the ticker against a stable peer baseline rather than against the whole market.
- Peer comparisons use the Portfolio Terminal coverage set and highlight nearby listed alternatives such as UNH, JNJ, PFE.
Sources
- Yahoo Finance quote dataopen →
Live quote, valuation, beta, yield, and volume fields used for UHS. Last refresh: Oct 13, 2026, 9:18 AM.
- Portfolio Terminal methodologyopen →
Explains how analytics, refresh cadence, and portfolio interpretation work across the product.
- Peer set and coverage context
Comparative context for this page is anchored around nearby tracked names such as UNH, JNJ, PFE.
What Universal Health Services does
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities in the United States. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; capital resources; and various management services, including central purchasing, information services, finance and control systems, facilities planning,…
Employees
102,000
Industry
Medical Care Facilities
Headquarters
King of Prussia, United States
What analysts expect
UHS carries a buy consensus from 17 analysts, with an average price target of $194.94 versus $178.83 today (+9.0%). Targets are estimates and can move quickly after earnings.
Consensus aggregated by Yahoo Finance. Targets are estimates, not forecasts.
How the business is doing
UHS generated $18.11B in trailing revenue (8.3% year over year), with a 8.4% net margin, and $498.32M of free cash flow, against $5.12B of net debt.
The numbers, year by year
| Fiscal year | Revenue | Gross profit | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|---|
| 2025 | $17.36B | $15.71B | $1.99B | $1.49B | $23.42 | $824.55M |
| 2024 | $15.83B | $14.24B | $1.68B | $1.14B | $17.16 | $1.12B |
| 2023 | $14.28B | $12.75B | $1.18B | $717.79M | $10.35 | $524.74M |
| 2022 | $13.40B | $11.93B | $1.00B | $675.61M | $9.23 | $262.02M |
When it reports next
Estimates aggregated by Yahoo Finance. Dates move and estimates change until the report lands.
Which ETFs hold it
UHS is in 5 of the 30 ETFs we track. It weighs most in XLV: 0.15% of the fund, holding #58 of 62.
Famous investors who hold it
UHS is in the latest 13F of 1 of the 15 famous investors we follow. Ray Dalio (Bridgewater Associates) holds the most of it: 0.14% of the portfolio, position #117 of 992, as of Q2 2026.
How it sits in healthcare
Defensive sector including pharmaceuticals, biotech, medical devices, and healthcare services.
The companies it competes with
UHS beside the healthcare names it is usually measured against.
What the chart is saying
Back above its 50-day average, still under the long-term trend.
recovering- Price is 2.7% above its 50-day average and 0.3% below its 200-day.
- RSI at 57 is neither stretched nor washed out.
- The nearest ceiling is $180.68 (+1.0%), the nearest floor $174.94 (-2.2%).
A description of the chart, not advice. Indicators describe what the price has done; none of them knows what it does next.
Questions people ask about it
Is UHS a good investment in 2026?
Universal Health Services trades at a P/E ratio of 7.4, with medium volatility (21.9% annualized). The stock is in a consolidation phase.
What is the risk level of UHS?
Based on 30-day volatility of 21.9%, UHS has MEDIUM risk. Beta of 1.03 indicates higher sensitivity to market movements than average.
Does UHS pay dividends?
Yes, Universal Health Services has a dividend yield of 0.45%.
How far is UHS from its all-time high?
Universal Health Services is 27.4% below its all-time high of $246.33, reached in November 2025. Over the 10 years to the end of September 2026, with dividends reinvested, it returned +47.7%, against +312.9% for the S&P 500 (SPY).
Which ETFs hold UHS?
5 of the 30 popular ETFs we track hold Universal Health Services. The largest weights: XLV (0.15%), SPY (0.01%), IVV (0.01%), VOO (0.01%) and VTI (0.01%). Measured on each issuer's full holdings file, dated August 31 to September 24, 2026.
How much of VOO is UHS?
0.01%, as of August 31, 2026: UHS is holding #486 of 505 in Vanguard's file for VOO. $1,000 in VOO puts about $0.14 in Universal Health Services.
Which famous investors own UHS?
Ray Dalio (0.14% of Bridgewater Associates's 13F), according to their latest Form 13F filings with the SEC (Q2 2026). A 13F lists US long positions 45 days after the quarter ends, so it can be out of date.
What is the analyst price target for UHS?
The average analyst price target for Universal Health Services (UHS) is $194.94 based on 17 analyst estimates, about 9.0% above the current price of $178.83. The published range runs from $166.00 to $290.00.
How much revenue does UHS generate?
Universal Health Services reported $18.11B in trailing twelve-month revenue. Revenue growth is running at 8.3% year over year. Net margin sits at 8.4%. Figures are aggregated from company filings by Yahoo Finance and refresh on an hourly cadence.
Compare UHS with anything
Five years side by side: what $10,000 became, how far each fell, whether they move together.